Skip to main content
PepStack
Blutwerte · Marker

TIBC

Total Iron Binding Capacity · Totale Eisenbindungskapazität

Eisen & Anämie
Einheit:
µmol/L

TIBC quantifies the total capacity of blood proteins, primarily transferrin, to bind and transport iron.

Reference Ranges

Reference
4572µmol/L
45
72
LowNormalHigh
Reference
Unit · µmol/L

Reference ranges may vary slightly depending on the laboratory and population. No significant sex-specific differences.

Overview

Übersicht

Total Iron Binding Capacity (TIBC) is a blood test that measures the maximum amount of iron that can be bound by proteins in the blood, primarily transferrin. This marker reflects the body's capacity to transport iron, which is crucial for various physiological functions, including oxygen transport and DNA synthesis. Clinically, TIBC is an important marker in the evaluation of iron metabolism and is often used in conjunction with other tests to diagnose iron deficiency anemia (IDA) and other disorders of iron metabolism. Elevated TIBC levels are typically associated with iron deficiency, as the body increases transferrin production to maximize iron transport. Conversely, low TIBC levels may indicate conditions such as chronic inflammation, malnutrition, or hemochromatosis, where iron is excessively stored in tissues. In the context of athletic performance and biohacking, maintaining optimal iron levels is crucial for endurance and overall energy metabolism. Researchers have found that lower TIBC levels are associated with longevity, suggesting that efficient iron utilization and minimal iron overload may contribute to a longer lifespan. However, TIBC values can be influenced by various factors, including nutritional status, inflammation, and liver function. It's important to consider these confounders when interpreting TIBC results. Additionally, fasting is not required for TIBC testing, but it is often performed alongside other iron studies that may require fasting for accurate results.

Klinische Bedeutung

Elevated TIBC values typically indicate iron deficiency, as the body increases transferrin production to enhance iron transport. Reduced TIBC values may suggest conditions such as chronic inflammation, malnutrition, or iron overload disorders like hemochromatosis.

Dynamics

Trend Interpretation

Rising Values

Progressively rising TIBC values suggest worsening iron deficiency. Retesting is recommended every 3 months if outside the optimal range.

Falling Values

Progressively falling TIBC values may indicate improving iron status or the presence of chronic disease.

Re-test Interval

3 months if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Iron deficiency anemia
  • Pregnancy
  • Oral contraceptive use
  • Chronic blood loss
  • Acute hepatitis
Cause

Low Levels

  • Chronic inflammation
  • Malnutrition
  • Hemochromatosis
  • Liver disease
  • Nephrotic syndrome
Protocol

How to Optimize

Lever

Lifestyle

  • Regular physical activity
  • Stress management
  • Adequate sleep
Lever

Nutrition

  • Increase dietary iron intake
  • Consume vitamin C-rich foods
  • Limit calcium-rich foods with iron meals
Lever

Supplementation

  • Iron supplements
  • Vitamin C supplements

Note:

Consult a physician before starting iron supplementation, especially if not diagnosed with iron deficiency.

Testing Guidelines

Fasting Not Required
Not Time-Sensitive

Iron levels can vary throughout the day; morning tests are preferred.

Testing Frequency

Annually for individuals with known iron metabolism issues, or as part of a comprehensive anemia workup.

Interfering Factors

  • Recent blood transfusion
  • Oral contraceptive use
  • Acute illness

Related Peptides & Hormones

Hepcidin

May affect

hormone or peptide

Open Research Questions

Current research suggests that reference ranges and optimal targets for total iron-binding capacity (TIBC) in diverse populations remain debated, particularly in relation to confounding factors such as inflammation and nutritional status. Researchers have not yet established the precise role of TIBC in differentiating types of microcytic anemia beyond iron deficiency. Additionally, clinical questions remain unanswered regarding the impact of TIBC variations on long-term outcomes in conditions like chronic kidney disease and their relationship with overall mortality.

20 Research Publications

1,330

Total Citations

12

Human/RCT

13.7

Avg. Influence

2025

Latest

Sort
Filter
#01

A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients.

HumanInfluence65.0
944
Researchers developed a comprehensive Malnutrition-Inflammation Score (MIS) that includes total iron binding capacity as a component. They found that the MIS correlated significantly with hospitalization and mortality in maintenance hemodialysis patients, suggesting its potential as a predictor of clinical outcomes.
View on PubMed
#02

Laboratory diagnosis of thalassemia.

UnknownInfluence9.0
202
This study focused on the laboratory diagnosis of thalassemia, noting that both α- and β-thalassemia carriers present with microcytic parameters. Researchers emphasized the importance of iron status assessment to differentiate thalassemia from iron deficiency anemia.
View on PubMed
#03

Evaluation of microcytosis.

Van Vranken Michele · American family physician · 2010

Unknown
49
Researchers found that microcytosis is often an incidental finding, commonly caused by iron deficiency anemia and thalassemia trait. They emphasized the importance of serum ferritin measurement in evaluating microcytosis and identifying potential underlying blood loss.

Key findings

  1. 01Researchers found that microcytosis is usually discovered incidentally during blood tests.
  2. 02They observed that low ferritin levels indicate iron deficiency, which is often due to blood loss, primarily from the gastrointestinal tract.
  3. 03The study noted that additional tests may be needed if ferritin levels are not low to determine the cause of microcytosis.
View on PubMed
#04

Blood biomarker profiles and exceptional longevity: comparison of centenarians and non-centenarians in a 35-year follow-up of the Swedish AMORIS cohort.

Murata Shunsuke, et al. · GeroScience · 2024

HumanInfluence3.0
33
This study examined biomarker profiles in centenarians compared to shorter-lived individuals, finding that higher levels of iron and total cholesterol were associated with reaching age 100. Researchers observed that centenarians had more favorable biomarker values from age 65 onwards, suggesting potential genetic or lifestyle factors influencing longevity.

Key findings

  1. 01Higher levels of total cholesterol and iron, along with lower levels of glucose and other biomarkers, were linked to reaching age 100.
  2. 02Centenarians showed consistent and favorable biomarker profiles starting from age 65.
  3. 03Differences in biomarker values between centenarians and shorter-lived individuals indicate that genetics and lifestyle factors may play a significant role in longevity.
View on PubMed
#05

Genome-wide meta-analysis of iron status biomarkers and the effect of iron on all-cause mortality in HUNT.

Meta-AnalysisInfluence3.0
33
This genome-wide meta-analysis examined iron status biomarkers and their effects on all-cause mortality. Researchers found evidence of harmful effects associated with increased serum iron and transferrin saturation, contributing to understanding the genetic factors influencing iron status.
View on PubMed
#06

Revisiting Iron Metabolism, Iron Homeostasis and Iron Deficiency Anemia.

Review
31
Researchers found that iron deficiency anemia (IDA) is a prevalent condition affecting various populations, with laboratory features including low serum iron and increased total iron binding capacity. They emphasized the importance of identifying underlying causes for effective management. The review highlighted that approximately 2 billion people worldwide are affected by IDA.
View on PubMed
#07

Microcytic anemia.

UnknownInfluence1.0
10
This study highlighted that iron deficiency anemia is the most common type of microcytic anemia. Researchers noted that low serum ferritin is the best parameter for diagnosing iron deficiency, and emphasized the need to investigate underlying causes when anemia is identified.
View on PubMed
#08

Causal Association of Iron Status With Functional Outcome After Ischemic Stroke.

HumanInfluence1.0
8
Researchers investigated the causal relationship between iron status and functional outcomes after ischemic stroke. They found that higher levels of total iron binding capacity and serum iron were associated with poorer functional outcomes, suggesting a potential modifiable risk factor.
View on PubMed
#09

Appropriate Method of TIBC Estimation in Reference to Serum Transferrin Levels.

Human
7
Researchers compared different methods for estimating total iron binding capacity (TIBC) and their correlation with serum transferrin levels. They found that the direct method of TIBC estimation showed a strong positive correlation with serum transferrin, making it the most reliable method.
View on PubMed
#10

Clinical Significance of Serum Iron Metabolism-Related Markers in Patients with Nasopharyngeal Carcinoma.

Human
7
This study assessed iron metabolism in nasopharyngeal carcinoma patients, finding lower levels of serum iron, TIBC, and transferrin compared to healthy controls. Researchers observed that the degree of iron deficiency correlated with tumor burden and metastasis.
View on PubMed

Publication Trend

Research publications about TIBC over time

9total
1
'01
1
'10
1
'15
1
'16
1
'20
1
'21
2
'23
1
'24

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer